IndraLab
Statements
sparser
"NSC348884, a small‐molecule inhibitor targeting NPM1, disrupts its biological function via oligomerization interference (Figure xref , Supporting Information). [ xref , xref ] To assess the therapeutic potential of targeting the CSN6‐NPM1 axis for suppressing PDAC progression and overcoming gemcitabine resistance, we therefore treated PDAC cell lines with NSC348884."